Formosa Laboratories, Inc.
4746
Rank in Stocks
#18527
Formosa Laboratories, Inc., together with its subsidiaries, engages in the... Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and other areas; and injectables in the areas of IDA, MRI agents, oncology, and others. The company also provides contract development and manufacturing services, including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization; injectable manufacturing and secondary packaging, labeling, and serialization services; custom fermentation services; and peptide synthesis services. In addition, it offers antibody-drug conjugates services comprising antibody development and manufacture; peptide and polymer drug conjugation; linker-payload design, synthesis, and manufacturing; bio-conjugation and purification; cytotoxic liquid-filled and lyophilized product from pre-formulation studies to manufacture; and regulatory support. Further, the company is involved in chemical trading and investment activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan City, Taiwan.
Share Price
$1.42
Last synced: 2026-11-13
Market Cap
$129.95M
Change (1 day)
1.87%
Change (1 year)
-33.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Formosa Laboratories, Inc. (4746)
Category
Healthcare
EPS for Formosa Laboratories, Inc. (4746)
EPS as of September 2026 TTM: $0.10
According to Formosa Laboratories, Inc.'s latest financial reports, its current EPS (TTM) is $0.10. At the end of 2025 the company had an EPS of $0.12, an increase over its 2024 EPS of $0.04.
EPS history for Formosa Laboratories, Inc. from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.10 | -16.17% |
| 2025 | $0.12 | 192.98% |
| 2024 | $0.04 | 16.67% |
| 2023 | $0.03 | -41.74% |
| 2022 | $0.06 | -85.10% |
| 2021 | $0.39 | 192.94% |
| 2020 | $0.13 | -1,081.75% |
| 2019 | $-0.01 | -123.54% |
| 2018 | $0.06 | -34.09% |
| 2017 | $0.09 | -47.72% |
| 2016 | $0.17 | 67.89% |
| 2015 | $0.10 | 2.86% |
| 2014 | $0.10 | -400.92% |
| 2013 | $-0.03 | -1,303.70% |
| 2012 | 0.00 | -97.62% |
| 2011 | $0.11 | -17.02% |
| 2010 | $0.14 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $1.69 | 1,579.92% |
US
|
|
| $1.90 | 1,787.48% |
SE
|
|
| $6.83 | 6,693.84% |
FR
|
|
| $0.02 | -80.62% |
HK
|
|
| $2.81 | 2,694.23% |
IT
|
Questions about Formosa Laboratories, Inc.'s earnings per share (EPS)
What is Formosa Laboratories, Inc.'s earnings per share (EPS)?
Formosa Laboratories, Inc.'s earnings per share (EPS) over the last twelve months is $0.10, as of Sep 2026.
What was Formosa Laboratories, Inc.'s earnings per share (EPS) in 2025?
In 2025, Formosa Laboratories, Inc.'s earnings per share (EPS) was $0.12, 200.00% more than in 2024 ($0.04).
How has Formosa Laboratories, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Formosa Laboratories, Inc.'s earnings per share (EPS) went from $0.13 to $0.12, an average decline of 1.59% a year.
How does Formosa Laboratories, Inc.'s earnings per share (EPS) compare with similar companies?
Formosa Laboratories, Inc.'s earnings per share (EPS) ($0.10) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.83.